CAS 69884-00-0 występuje w naszej ofercie pod nazwami: Pseudoginsenoside f11, 95%, Pseudoginsenoside F11, >95% (HPLC), Pseudoginsenoside– F11, Pseudoginsenoside F11/ 98.76% (existing batch purity), Pseudoginsenoside FII. Oferty producentów: Combi-blocks, TRC, GLPBio, TargetMol, Biosynth. Dostępne opakowania: 100mg, 250mg, 25mg, 10mg, 5mg, 10mM (in 1ml dmso), 50mg, 10mM/1mL.
(2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol (CAS 69884-00-0) to związek chemiczny o wzorze sumarycznym C42H72O14 i masie molowej 801.0 g/mol. Nazwa systematyczna IUPAC: (2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol. InChIKey: JBGYSAVRIDZNKA-NKECSCAMSA-N.
| Wzór sumaryczny | C42H72O14 |
|---|---|
| Masa molowa | 801.0 g/mol |
| Nazwa IUPAC | (2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol |
| InChIKey | JBGYSAVRIDZNKA-NKECSCAMSA-N |
| SMILES | C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2O[C@H]3C[C@@]4([C@H](C[C@H]([C@H]5[C@]4(CC[C@@H]5[C@@]6(CC[C@@H](O6)C(C)(C)O)C)C)O)[C@@]7([C@@H]3C([C@H](CC7)O)(C)C)C)C)CO)O)O)O)O)O |
Dane obliczone przez PubChem (NCBI)